Loading
Bruce C. Cozadd received $15.5M in total compensation as Chairperson and CEO of Jazz Pharmaceuticals plc in FY2024. The largest component was $12.8M in stock awards. Source: SEC DEF 14A.
In fiscal year 2024, Bruce C. Cozadd, Chairperson and CEO of Jazz Pharmaceuticals plc (JAZZ), received total compensation of $15.5 million.
Bruce C. Cozadd's compensation breakdown includes: base salary of $1.2 million, stock awards valued at $12.8 million, non-equity incentive compensation of $1.5 million, and other compensation of $32K.
Jazz Pharmaceuticals plc's top 6 named executive officers received combined total compensation of $39.0 million in fiscal year 2024.
The named executive officers disclosed in Jazz Pharmaceuticals plc's 2024 proxy statement are:Bruce C. Cozadd (Chairperson and CEO) with total compensation of $15.5 million, Renée Galá (President and COO) with total compensation of $6.6 million, Robert Iannone (M.D., M.S.C.EExecutive Vice President,Global Head of R&D) with total compensation of $5.7 million, Philip L. Johnson (Executive Vice President and CFO) with total compensation of $5.2 million, Samantha Pearce (Executive Vice President CCO) with total compensation of $4.5 million, and Patricia Carr (Senior Vice President and CAO (Former Interim Principal Financial Officer)) with total compensation of $1.5 million.
Source Filing
Executive Record
Bruce C. Cozadd
Chairperson and CEO
Reported Pay
$15.5M
Summary compensation table total · FY2024
Findings
Reviewing FY2024 compensation of $15.5M against shareholder return and the latest filing-backed pay disclosures.
Spread between reported pay and stock performance is pending computation.
Evidence is sourced from the latest executive compensation filing and return series for JAZZ.
Team view
6 executives
Chairperson and CEO
Total PayFY2024
$15.5M
President and COO
Total PayFY2024
$6.6M
M.D., M.S.C.EExecutive Vice President,Global Head of R&D
Total PayFY2024
$5.7M
Executive Vice President and CFO
Total PayFY2024
$5.2M
Executive Vice President CCO
Total PayFY2024
$4.5M
Senior Vice President and CAO (Former Interim Principal Financial Officer)
Total PayFY2024
$1.5M
Ask a question about this filing
01FY2024 total compensation breakdown
$15.5M total compensation
Bruce C. Cozadd earned $15.5M in FY2024 — here's how that breaks down.
$12.8M
82% of total
$1.5M
10% of total
$1.2M
8% of total
$31.8K
0% of total
Activity timeline · FY2024
Recent events from filings
A pay-performance summary will appear here once the verdict loads above.
02Pay changes vs. stock performance
1 year of data
Peer context
Dashed line marks the large-cap median compensation benchmark for companies around $12.1B market cap, based on 312 peers in this size band.
03Recent insider trades by officers and directors
~24 trades
04Showing FY2024 data (latest available)
FY2026 does not include director compensation in our current dataset, so we're showing the latest board table we found.
We're loading the latest director compensation and board makeup.
05Take action on executive compensation
Shareholder activism tools
Start or join campaigns to engage with JAZZ's board on executive compensation, governance, and shareholder proposals.
Activism Beta — Sign in to start or join campaigns
06For analysts and deep research
Historical compensation data from latest proxy filing
| Year | Executive | Salary | Bonus & Incentive | Stock Awards | Option Awards | Other Adj. | Total |
|---|---|---|---|---|---|---|---|
| 2024 | Bruce C. Cozadd Chairperson and CEO | $1.20M | $1.49M | $12.8M | $0.00M | $0.03M | $15.5M |
Salary = base cash pay. Bonus & Incentive combines annual bonus and non-equity plans. Equity amounts are grant-date fair values. Other Adj. captures pension changes, perquisites, and any reconciliation items so the total matches the reported figure.
Get one email when new executive compensation data is filed and processed.
Jazz Pharmaceuticals plc (JAZZ) — Key Facts
Last updated Apr 4, 2026 · DEF 14A filed Jun 6, 2025
| CEO | Bruce C. Cozadd, Chairperson and CEO |
|---|---|
| Fiscal year | FY2024 |
| Total compensation | $15.5M |
| Base salary | $1.2M |
| Stock awards | $12.8M |
| Other compensation | $32K |
| Source | DEF 14A, 2025-06-06 |
Bruce C. Cozadd, the Chairperson and CEO of Jazz Pharmaceuticals plc, received total compensation of $15.5 million in fiscal year 2024. This includes base salary of $1.2 million and stock awards valued at $12.8 million.
Bruce C. Cozadd's base salary at Jazz Pharmaceuticals plc is $1.2 million per year as of fiscal year 2024. However, total compensation including stock awards, bonuses, and other benefits is $15.5 million.
Jazz Pharmaceuticals plc's CEO, Bruce C. Cozadd, earned $15.5 million in total compensation for fiscal year 2024. The majority of this compensation comes from stock awards ($12.8 million) rather than base salary ($1.2 million).